glp-1 average weight loss medications are changing the landscape of obesity treatment, but having realistic expectations is really important. Clinical trials showed weight loss of approximately: • ~15% body weight with semaglutide • ~ GLP-1 Medications for Weight Loss:

For compounding pharmacies or physicians that have been compounding semaglutide products during the shortage, the FDA has set clear deadlines for ceasing general semaglutide compounding practices: State-licensed pharmacies or physicians compounding semaglutide under Section 503A of the FD&C Act must stop compounding, distributing, or dispensing semaglutide injections that are essentially copies of an FDA-approved product by April 22, 2025

PlexusDx maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to generate personalized treatment recommendations

The growth hormone pulse that occurs during deep sleep is one of the body most powerful fat-mobilizing signals, and restoring that sleep architecture is foundational to any effective peptide protocol

Exercise intensity adjustments, particularly adding or increasing resistance training, can also shift the equation

The pre-proglucagon system constitutes interesting candidates as potential targets for new anti-obesity drugs

Common approaches include: 16:8 fasting (eating within an eight-hour window) 12:12 as a gentle starting point 3